AAPS PharmSciTech

, Volume 14, Issue 2, pp 511–516 | Cite as

Application of Physicochemical Properties and Process Parameters in the Development of a Neural Network Model for Prediction of Tablet Characteristics

  • Tamás Sovány
  • Kitti Papós
  • Péter KásaJr.
  • Ilija Ilič
  • Stane Srčič
  • Klára Pintye-Hódi
Research Article


The importance of in silico modeling in the pharmaceutical industry is continuously increasing. The aim of the present study was the development of a neural network model for prediction of the postcompressional properties of scored tablets based on the application of existing data sets from our previous studies. Some important process parameters and physicochemical characteristics of the powder mixtures were used as training factors to achieve the best applicability in a wide range of possible compositions. The results demonstrated that, after some pre-processing of the factors, an appropriate prediction performance could be achieved. However, because of the poor extrapolation capacity, broadening of the training data range appears necessary.

Key words

artificial neural network mechanical properties plasticity surface characteristics tablet 



The work was supported by the Project named “TÁMOP-4.2.1/B-09/1/KONV-2010-0005, –creating the Center of Excellence at the University of Szeged” is supported by the European Union and co-financed by the European Regional Fund and by the bilateral Hungarian-Slovenian Science and Technology Transfer Project SI-17/2009.


  1. 1.
    Bourquin J, Schmidli H, van Hoogevest P, Leuenberger H. Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form. Eur J Pharm Sci. 1998;7:5–16.CrossRefPubMedGoogle Scholar
  2. 2.
    Dou Y, Qu N, Wang B, Chi YZ, Ren YL. Simultaneous determination of two active components in compound aspirin tablets using principal component artificial neural networks (PC-ANNs) on NIR spectroscopy. Eur J Pharm Sci. 2007;32:193–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Shao Q, Rowe RC, York P. Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation. Eur J Pharm Sci. 2006;28:394–404.CrossRefPubMedGoogle Scholar
  4. 4.
    Barmpalexis P, Kachrimanis K, Georgiakis E. Solid dispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming. Eur J Pharm Biopharm. 2011;77:122–31.CrossRefPubMedGoogle Scholar
  5. 5.
    Belic A, Skrjanc I, Bozic DZ, Karba R, Vrecer F. Minimisation of the capping tendency by tabletting process optimization with the application of artificial neural networks and fuzzy models. Eur J Pharm Biopharm. 2009;73:172–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Belic A, Skrajanc I, Bozic DZ, Vrecer F. Tableting process optimization with the application of fuzzy models. Int J Pharm. 2010;389:86–93.CrossRefPubMedGoogle Scholar
  7. 7.
    Landin M, Rowe RC, York P. Establishing and analyzing design space in the development of direct compression formulations by gene expression programming. Int J Pharm. 2012;434:35–42.CrossRefPubMedGoogle Scholar
  8. 8.
    Takagaki K, Arai H, Takayama K. Creation of a tablet database containing several active ingredients and prediction of their pharmaceutical characteristics based on ensemble artificial neural networks. J Pharm Sci. 2010;99:4201–14.CrossRefPubMedGoogle Scholar
  9. 9.
    Onuki Y, Kawai S, Arai H, Maedea J, Takakagi K, Takayama K. Contribution of the physicochemical properties of active pharmaceutical ingredients to tablet properties identified by ensemble artificial neural networks and Kohonen’s self organizing maps. J Pharm Sci. 2010;101:2372–81.CrossRefGoogle Scholar
  10. 10.
    Mathias NR, Crison J. The use of modeling tools to drive efficient oral product design. AAPS J. 2012;14:591–600.CrossRefPubMedGoogle Scholar
  11. 11.
    Sovány T, Kása Jr P, Pintye-Hódi K. Comparison of halving of tablets prepared with eccentric and rotary tablet press. AAPS PharmSciTech. 2009;10:430–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Sovány T, Kása Jr P, Vakli K, Pintye-Hódi K. X-ray computed microtomography for the determination of the realtionships between structure and breaking of scored tablets. X-ray Spectrom. 2009;38:505–50.CrossRefGoogle Scholar
  13. 13.
    Sovány T, Kása Jr P, Pintye-Hódi K. Modeling of subdivision of scored tablets with the application of artificial neural networks. J Pharm Sci. 2010;99:905–15.PubMedGoogle Scholar
  14. 14.
    Stamm A, Mathis C. Verprelssbarkeit von festen Hilf- stoffen für Direkttablettierung. Acta Pharm Technol. 1976;22:7–16.Google Scholar
  15. 15.
    Fell JT, Newton JM. The tensile strength of lactose tablets. J Pharm Pharmacol. 1968;20:657–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Fell JT, Newton JM. Determination of the tablet strength by the diametral-compression test. J Pharm Sci. 1970;59:688–91.CrossRefPubMedGoogle Scholar
  17. 17.
    Schiffmann W, Joost M, Werner R. Comparison of optimized backpropagation algorithms Proc. of ESANN’93, Brussels 1993.Google Scholar
  18. 18.
    Aksu B, Paradkar A, de Matas M, Özer Ö, Güneri T, York P. Quality by design approach: application of artificial intelligence techniques of tablets manufactured by direct compression. AAPS PharmSciTech. 2012;13:1138–46.CrossRefPubMedGoogle Scholar
  19. 19.
    Dennis JE, Moree JJ. Quasi-Newton methods, motivation and theory. SIAM Rev. 1977;19:46–89.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2013

Authors and Affiliations

  • Tamás Sovány
    • 1
  • Kitti Papós
    • 1
  • Péter KásaJr.
    • 1
  • Ilija Ilič
    • 2
  • Stane Srčič
    • 2
  • Klára Pintye-Hódi
    • 1
  1. 1.Department of Pharmaceutical TechnologyUniversity of SzegedSzegedHungary
  2. 2.Department of Pharmaceutical TechnologyUniversity of LjubljanaLjubljanaSlovenia

Personalised recommendations